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Abstract
Background: The replicative cycle of chikungunya virus (CHIKV), an alphavirus that recently re-emerged in India and in
Indian Ocean area, remains mostly unknown. The aim of the present study was to investigate the intracellular trafficking
pathway(s) hijacked by CHIKV to enter mammalian cells.
Methodology/Principal Findings: Entry pathways were investigated using a variety of pharmacological inhibitors or
overexpression of dominant negative forms of proteins perturbating cellular endocytosis. We found that CHIKV infection of
HEK293T mammalian cells is independent of clathrin heavy chain and- dependent of functional Eps15, and requires integrity
of Rab5-, but not Rab7-positive endosomal compartment. Cytoskeleton integrity is crucial as cytochalasin D and nocodazole
significantly reduced infection of the cells. Finally, both methyl b-cyclodextrin and lysomotropic agents impaired CHIKV
infection, supporting that a cholesterol-, pH-dependent step is required to achieve productive infection. Interestingly,
differential sensitivity to lysomotropic agents was observed between the prototypal 37997 African strain of CHIKV and the
LR-OPY1 virus isolated from the recent outbreak in Reunion Island.
Conclusions: Together our data indicate that CHIKV entry in its target cells is essentially mediated by clathrin-independent,
Eps15-dependent endocytosis. Despite that this property is shared by the prototypal 37997 African strain of CHIKV and the
LR-OPY1 virus isolated from the recent outbreak in La Re ´union Island, differential sensitivity to lysomotropic agents may
support that the LR-OPY1 strain has acquired specific entry mechanisms.
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Introduction
Chikungunya virus (CHIKV) is member of the Togaviridae
family. It belongs to the Semliki Forest Virus (SFV) group and is
closely related to other viruses from the family of arthrogenic
alphaviruses,witha markedsimilaritywitho’nyong-nyong virus [1].
CHIKV is an enveloped single-stranded positive RNA virus. The
coding sequence comprising the nonstructural and structural
polyproteins is of approximately 12 kb [2]. According to the
genomic organization of other alphaviruses, the genome of CHIKV
is considered to be: 59-nsP1-nsP2-nsP3-nsP4-junction region-C-E3-
E2-6K-E1-poly(A)-39. Chikungunya virions are approximately
70 nm in diameter [3,4] and contain a spherical capsid with
icosahedral symmetry. Viral glycoproteins E1 and E2, embedded in
the lipid bilayer surrounding the viral capsid, direct the virus
attachment to the host cell and the fusion with cellular membranes.
Chikungunya virus is transmitted to humans by mosquito vectors
during blood feeding. Since the first isolation of CHIKV more than
50 years ago in Eastern and Central Africa [5], chikungunya
epidemics have been repeatedly recorded from various countries in
central, southern and western Africa [6,7,8], with a recent episode
traced in Kenya [9]. In Asia, CHIKV was isolated from Bangkok,
Thailand in 1958 [10] and repeated outbreaks have been recorded
since early 1960s [11,12,13,14]. From February 2005 to June 2006,
CHIKV caused an explosive burst in the Indian Ocean, originally
documented for Reunion Island [15] and next in neighboring
islands Seychelles, Madagascar, Mauritius and Mayotte [16,17].
During the same period, an outbreak of unprecedented magnitude
started in India, where more than 1.4 million persons have been
infected [18,19]. The detection of chikungunya fever cases in
travellers returning from known outbreak areas to regions where
mosquito species competent for CHIKV are widely distributed
[20,21,22], together with the CHIKV epidemics detected during
summer 2007 in the Emilia-Romagna Region, central Italy [23],
indicates that CHIKV may become a general threat for human
health in temperate areas.
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symptoms of incapacitating polyarthralgia with join pains, severe
myalgia, and a cutaneous rash. Despite chikungunya infection is
often a self-limiting illness and most patients recover completely
over a few weeks, 5% to 10% of patients experienced chronic
symptoms lasting a year or more [24,25]. During the recent
outbreak in Reunion Island, the detailed epidemiologic survey
revealed the appearance of severe neurologic symptom. Moreover,
at the end of the epidemic, an estimated 255 fatalities were
attributed to chikungunya infection [15]. Such symptoms have
never been documented in chikungunya epidemics raging in other
parts of the world. Although most countries where Chikungunya
rages lack of appropriate surveillance system, a special virulence of
the virus circulating during La Reunion outbreak can be
questioned. Phylogenetic analysis performed at different time
points during the epidemic revealed that genomes circulating in
the Indian Ocean were derived from an African ancestor
belonging to the Eastern-Central-South African (ECSA) group of
viruses [26]. Interestingly, the presence of the A226V mutation in
the E1 envelope gene sequence was detected in genomes of isolates
present at the epidemic peak [26]. During the same period, the
A226V mutation was evidenced in genomes of highly pathogenic
viruses circulating in the Indian state of Kerala [27] indicating that
this viral subtype retains a selective advantage. Substitution of the
A226 residue in E1, that was previously observed to impact
membrane fusion and more precisely cholesterol dependence,
using a SFV model of infection [28,29], was proposed to be
responsible for the increased transmissibility and higher epidemic
potential of CHIKV [26]. Although the role of this mutation is
unknown for human pathogenesis, it facilitates viral dissemination
in Aedes albopictus mosquito that served as a vector for CHIKV
during the recent Indian and the Indian Ocean area epidemics
[30,31].
If the replication cycle of alphaviruses has been largely studied
[2] and differences have been reported regarding the mechanisms
used to enter their target cell [32,33,34], CHIKV host-cell
interactions remain poorly documented [35]. In light of the
emergence of CHIKV in previously unaffected areas, and of the
recent report of a considerable proportion of severe symptomatic
cases, a thorough understanding of the routes used by this viral
agent to infect its target cells will help to rationally design antiviral
strategies that will protect humans against infection with CHIKV,
and perhaps related viruses with potential emergence in temperate
areas. In the present study, we performed a detailed investigation
of the largely unknown mechanisms of cellular entry of CHIKV
into mammalian cells. We examined the entry of CHIKV into
epithelial HEK293T cell cultures using a variety of strategies
perturbating cellular endocytosis, including treatment with
chemical inhibitors, expression of dominant negative proteins or
RNA interference. Given that a higher epidemic potential was
associated with the E1-A226V mutation, we performed compar-
ative studies using the 37997 African prototype strain and the LR-
OPY1 virus isolated during Reunion Island epidemic that bears a
mutated envelope glycoprotein. We demonstrate here that
CHIKV preferentially uses a clathrin-independent, Eps15-depen-
dent pathway to enter mammalian epithelial cells. Moreover,
functional Rab5-, but not Rab7-dependent compartments are
required for CHIKV to infect these cells. We also show that
membrane cholesterol as well as endosomal pH acidification is
required to reach a productive infection. Finally, integrity of the
cell cytoskeleton is required. Disregarding the presence of the
A226V mutation in E1 gene, similar requirement for entry were
shared by the 37997 strain and the LR-OPY1 isolate, including
cholesterol dependence. However, some differences observed
regarding sensitivity of these strains to lysomotropic agents suggest
that the LR-OPY1 strain may have acquired specific entry
mechanisms. Altogether, our data describe the cellular pathway
used by CHIKV to enter mammalian epithelial cells.
Methods
Cell lines
Human embryonic kidney (HEK293T) cells [36] were main-
tained at 37uC under 5% CO2 in DMEM (Lonza) containing 10%
inactivated fetal calf serum and 1% antibiotics. BHK-21 and Vero
cells used for virus production and titration were cultured under
similar conditions.
Production of viral stocks and titration
The CHIKV subgenomic clones pCHIKic4 (37997 strain) and
pCHIK-LRic (LR-OPY1 strain), and the full length CHIKV
subgenomic clones expressing GFP, pCHIKic-39GFP (37997-GFP
strain) and pCHIKic-LR-39GFP (LR-OPY1-GFP strain) have
been previously described [30,37]. Each infectious clone was
transcribed in vitro from the SP6 promoter using the mMESSAGE
mMACHINE kit (Ambion) following manufacturer’s instructions.
RNA (0.5 mg) was then electroporated into 5610
6 BHK-21 cells
with two pulses at 1.5 kV, 25 mF and ‘V. After two days, cell
culture supernatant was harvested, filtered through 0.22 mm filters,
aliquoted and stored at 280uC. Viral stocks were tittered using
Vero cell plaque assays [38].
RNA interference
Subconfluent cultures of HEK293T in 24-well plates were
transfected with 1.2 pmol of synthetic double stranded siRNA
complexes (Ambion) and 2 ml Interferin (PolyPlus Transfection), in
a final volume of 600 ml serum-free medium. The clathrin heavy
chain target sequence was GGUUGCUCUUGUUACGGAU.
The On Target plus control pool siRNA (Dharmacon) was used as
a control. After 72 h in culture, an aliquot of the cells was assayed
for clathrin heavy chain expression by immunoblotting using the
(N-19) anti-clathrin heavy chain mAbs from Santa Cruz
Biotechnologies Inc. The remaining cells were challenged with
CHIKV strains used at a multiplicity of infection (m.o.i.) of 5.
Inhibition of endosomal acidification
Inhibition of endosomal acidification was reached through the
use of chloroquine (100 mM), monensin (1 mM), NH4Cl (20 mM)
or bafilomycin A1 (100 nM). Control cells were treated with
equivalent dilutions of solvent. HEK293T cells (8610
4) were
seeded into 24 well plates, 24 hours before drug treatment. Cells
were then incubated for 1 h in fresh medium in the presence of
inhibitor before exposure to CHIKV at a m.o.i. of 5. After 2 hours
of infection, the cells were extensively washed with DMEM and
cultured for another 16 h in the presence of fresh medium before
analysis. To evaluate the capacity of drugs to inhibit intracellular
steps of viral replication, cells were challenged with CHIKV
(m.o.i. of 5), washed and maintained in culture for 4 hours before
the drugs or equivalent concentration of solvent are added to
culture medium. Infection levels were monitored after an
additional 16 h in culture.
Cholesterol depletion
Cholesterol depletion was achieved by treatment of HEK293T
cells with methyl b-cyclodextrin (Sigma). HEK293T cells (3610
5)
were seeded into 6-wells plates. After 24 h, cells were washed twice
with medium containing 10% FCS and treated with methyl b-
cyclodextrin for 1 h at 37uC in serum-free DMEM. After washing
Entry of Chikungunya Virus
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endocytosis before addition of CHIKV (m.o.i. of 5). Following
incubation for 2 h at 37uC, the drug was removed and the
infection allowed to proceed for 16 h at 37uC before analysis.
Cytoskeleton disruption
Nocodazole or cytochalasin D, purchased from Sigma, were
added to HEK293T cells at various concentrations ranging from
10 mMt o5 0 mM. After 2 hours in culture, the medium was
removed and the cells were challenged with CHIKV (m.o.i. of 5)
in the presence of the drug. CHIKV replication was monitored
after an additional 16 h in culture.
Acid-mediated endocytosis by-pass assay
Cells were pre-treated with inhibitors at their optimal concentration
for the appropriate time. Then the virus (m.o.i. of 5) was allowed to
bind to the cells for 30 min at 4uC. Infection was allowed to proceed by
incubating the cells for 30 min at 37uCe i t h e ri nn e u t r a l( p H7 . 4 )o r
acid (pH 5.0) PBS. After washes with neutral PBS, the cells were
cultured in DMEM medium for 16 hours in the presence of the
inhibitor. Infection of the cells was monitored by flow cytometry.
Inhibition of cells endocytosis
Inhibition of endocytosis was achieved by transfection of the
pEGFP-Eps15-PED95/295 plasmid encoding a GFP-tagged
dominant negative (DN) form of the epidermal growth factor
receptor pathway substrate 15 (Eps15). The pEGFP-Eps15-WT
encoding GFP-tagged wild type (WT) Eps15 was used as a control.
Expression of WT or DN Rab5 and Rab7 GTPases was obtained
by transfection of pQCXIP EGFP-Rab5-WT or pQCXIP EGFP-
Rab5-S34N and pQCXIP EGFP-Rab7-WT or pQCXIP EGFP-
Rab7-T22N plasmids respectively. Plasmids (1 mg) were transfect-
ed in semi-confluent HEK293T cells by calcium phosphate
precipitation. After twenty-four hours, culture supernatant was
removed and replaced by fresh medium. Then, the cells were
challenged with CHIKV and analyzed for virus susceptibility using
either immunofluorescence experiments or flow cytometry assays.
Indirect immunofluorescence (IF) and confocal
microscopy
Transfected cells challenged with CHIKV (m.o.i. of 5) were
washed in PBS, fixed and permeabilized for 30 minutes at 37uCi na
solution containing 4% paraformaldehyde and 0.1% Triton X100
(Sigma). The cells were saturated with PBS containing 2% FCS,
washed twicein PBS and incubated for 1 h at room temperature with
mAbs C42, an IgG2a antibody raised to Semliki Forest nucleocapsid
that reacts with CHIKV capsid protein, [39] kindly provided by Dr.
Irene Greiser-Wilke, School of Veterinary Medicine (Hannover,
Germany). After washes in PBS, cells were incubated with Alexa
Fluor 594-conjugated anti-mouse Ig secondary antibody for 30
minutes at RT (Invitrogen). Coverslips were washed, mounted with
ProLong Gold antifade reagent (Invitrogen) and examined using a
confocal microscope. Transferrin uptake control was performed by
incubating the cells with Alexa-594-labelled transferrin (5 mg/ml) for
30 min at 37uC .C e l l sw e r et h e nw a s h e dt or e m o v ea n y
uninternalized ligand, fixed and processed as described above.
Flow Cytometry
Cells challenged for 16 h with CHIKV (m.o.i. of 1) were fixed
with a 4% paraformaldehyde solution for 20 min at 4uC.
Intracellular labelling of CHIKV antigens was performed by
incubating the cells for 1 h at 4uC with mAbs C42 in the presence
of 0.1% saponine. After washes with 0.1% saponine in PBS, bound
antibodies were detected by addition of Spectral Red (SPRD)
conjugated secondary IgG (Beckman Coulter) and incubation for
45 min at 4uC. SPRD IgG isotype was used as a control.
Fluorescence intensity was recorded (20,000 events) on a
COULTER EPICS XL Flow Cytometer (Beckman Coulter).
Results
CHIKV infection of mammalian cells is dependent on
Eps15
To characterize the entry route used by CHIKV, we examined
the effects on CHIKV infection of a series of chemical inhibitors or
well-characterized dominant negative (DN) mutants or siRNA
interfering with endocytosis. The experimental model used to
achieve this goal consisted of in vitro infection of the mammalian
epithelial-derived HEK293T cell line, previously reported to be
highly susceptible to CHIKV [40]. Considering this experimental
model we addressed the role of Eps15, an actor of early
endocytosis. Eps15 is a component of clathrin-coated pits where
it interacts with adaptor protein (AP)-2, the major clathrin adaptor
complex. More recently, Eps15 was also reported to play an
important function in coupling cargo internalization to clathrin-
independent endocytosis [41]. The role of Eps15 in mediating
entry of CHIKV into mammalian cells was addressed by mean of
overexpression of Eps15D95/295, a dominant negative (DN)
mutant of Eps15 [42]. Transfection of GFP-tagged wild-type
Eps15 (WT Eps15) or Eps15D95/295 (DN Eps15) resulted in over
85% GFP expression as determined by flow cytometry analysis
(data not shown). To confirm the effect of Eps15-encoding vectors
on endocytosis, uptake of transferrin, a ligand known to enter into
the cells using an Eps15-dependent pathway, was investigated
(Figure 1A). As expected, transferrin endocytosis was abrogated in
cells expressing DN Eps15 but remained unaffected in cells
expressing WT Eps15. When transfected cells were challenged
with the 37997 CHIKV strain, the percentage of cells positive for
viral antigens was markedly reduced in cells expressing DN Eps15
when compared with that in cells over-expressing WT Eps15
(Figure 1B). To quantitatively assess the contribution of functional
Eps15 in CHIKV infection, similar experiments were performed
where cells expressing WT Eps15 or DN Eps15, exposed to
CHIKV, were permeabilized and labelled for intracytoplasmic
viral antigens using antibodies reacting with the viral capsid
protein before flow cytometry analysis. For each condition, the
percentage of CHIKV-infected cells was monitored among the
population of transgene-expressing cells (GFP expressing cells). A
60% reduction of CHIKV-positive cells resulted from disruption
of Eps15 activity following expression of DN Eps15 when
compared with mock transfected cells (Figure 1C). In contrast,
overexpression of WT Eps15 did not significantly alter the level of
CHIKV infection when compared with control conditions.
Altogether, our results indicate that CHIKV entry into HEK293T
cells requires functional Eps15.
Evaluating the role of clathrin-dependent endocytosis in
CHIKV entry into epithelial mammalian cells
To decipher with the role of clathrin-dependent endocytosis in
CHIKV infection, we investigated the consequence of clathrin
heavy chain (CHC) knock out using RNA interference. At 72 h
post-transfection, we found that siRNA specific for CHC almost
abolished clathrin expression whereas protein levels remained
unaffected in cells transfected with irrelevant siRNA (Figure 1D,
lower panel). Then, siRNA-transfected cells were challenged with
CHIKV. Using this experimental model, no significant difference
was observed between cells knocked-down for CHC or cells
Entry of Chikungunya Virus
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inhibition of CHC expression does not modify the capacity of
HEK293T cells to be infected with CHIKV, supporting that the
pathways used to infected this particular cell line is independent of
endocytosis by clathrin-coated pits. Because of this unexpected
result, we have reanalyzed the role of clathrin-dependent
endocytosis using a second epithelial cell line. Using experimental
procedures identical to those used for HEK293T cells, we found
that CHIKV infection level was similar in Hela cells expressing
control siRNA or showing a drastic decrease in CHC expression
due to transfection of specific RNA (Figure S1). These results
corroborate data obtained with HEK293T cells.
CHIKV infection of mammalian cells is inhibited by
lysomotropic agents
The contribution of low endosomal pH was next investigated in
CHIKV infection. HEK293T cells were treated with various
lysomotropic agents prior to viral challenge, including primary
amines ammonium chloride (NH4Cl), chloroquine that crosses the
membranes and buffers the endosomal medium against acidification,
monensin, a cationic ionophore which uncouples the sodium/
potassium gradient acrossendosomal membranes required for proton
accumulation into endosomes, and bafilomycin A1, a mammalian
vacuolar-type-H
+-ATPase inhibitor that prevents acidification of the
endosomal compartment. Then the cells were challenged with the
well characterized 37997-GFP CHIKV clone containing a green
fluorescent protein (GFP) coding sequence in the 39of the open
reading frame coding for the non structural proteins [37]. We
previously reported the relevance of the 37997-GFP subgenomic
clone for molecular studies of CHIKV life cycle [37]. Viral inputs
required to reach significant, non saturating levels of infection in this
particular cell line (fixed to GFP expression in 60% of the cell culture)
were established from preliminary experiments (Figure S2). After
16 h in culture, quantification of GFP-positive cells by flow cytometry
Figure 1. Functional Eps15 but not clathrin heavy chain expression is required for infection by CHIKV. HEK293T cells were transfected
with plasmids encoding either a GFP-labelled wild type Eps15 (WT) or the GFP-tagged dominant negative Eps15D95/295 mutant (DN) and
maintained for 36 h in culture. (A) Cells were incubated with Alexa595-labelled transferrin for 30 min at 37uC and uptake by transfected cells was
monitored using immunofluorescence microscopy. (B) Transfected cells were challenged with CHIKV for 4 h at 37uC (37997-CHIKV strain used at a
m.o.i. of 5) and the presence of intracellular viral antigens was detected using a mAbs C42 reacting with CHIKV and Texas-red-conjugated secondary
antibodies. (C) Tansgene-expressing cells positive for intracellular CHIKV antigens were quantified from panel (B) by flow cytometry. Values are the
mean of 4 separate experiments performed in triplicate 6 SD. (D) Cells transfected with siRNA targeting the clathrin heavy chain (CHC) or with control
siRNA (Ctrl.) were challenged with 37997-CHIKV. Levels of infection were monitored by quantification of GFP-positive cells using flow cytometry
(upper panel). Levels of CHC expression in transfected cells were analyzed by immunoblot analysis. Actin expression was used to monitor proteins
level in each sample (lower panel).
doi:10.1371/journal.pone.0011479.g001
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chloroquine prior to virus exposure dramatically reduced CHIKV-
driven GFP expression without affecting cell viability (Figure 2A).
Similar range of inhibition was measured using a lower dose of
chloroquine (10 mM) (data not shown). Comparable results were
obtained when the cells were exposed to monensin or NH4Cl or
bafilomycin A1 before addition of CHIKV to the cell culture. In
order to ascertain that inhibition of CHIKV infection was not due to
any effect of inhibitors on a post-fusion step of the virus life cycle,
similar experiments were repeated where infection was allowed to
proceed for 4 hours before drug treatment. In these conditions, the
presence of 100 mM chloroquine or 100 nM bafilomycine allowed
infection of over 60% of cells when compared with control conditions
(Figure 2B). These data support that both inhibitors have a limited
effect on post-fusion steps of CHIKV replication. Thus early CHIKV
infection is sensitive to endosomal pH neutralization and requires
acidification of the endosomal compartment to productively infected
mammalian epithelial cells.
CHIKV infection is inhibited by methyl b-cyclodextrin
treatment
Studies of alphaviruses have identified lipids as possible
cofactors for critical steps in infection. Mainly, cholesterol is
required in vivo to permit fusion of alphaviruses with the endosome
membrane of the host cell [43]. To evaluate the role of membrane
cholesterol in CHIKV infection, HEK293T cells were pre-treated
with increasing concentrations of methyl b-cyclodextrin (mCD), a
potent cholesterol depleting agent, and then challenged with the
37997-GFP CHIKV strain. Quantitative analysis of CHIKV
infection using flow cytometry revealed that the percentage of
CHIKV-positive cells was reduced by 63% at the highest dose of
mCD used (20 mM) (Figure 3). This concentration of mCD was
previously reported to significantly deplete membrane cholesterol
and inhibit transferrin endocytosis [44]. Cell viability was
unaffected by any dose tested in these experiments. Accordingly,
mCD treatment significantly reduces CHIKV infection of
HEK293T mammalian cells.
Functional Rab5, but not Rab7, is required for infection of
mammalian cells by CHIKV
To gain insight into the route of endosomal delivery of CHIKV
into mammalian cells, HEK293T cells were transfected with GFP-
tagged constructs expressing WT or DN forms of Rab5 or Rab7,
two Rab GTPases required for transport of cargoes to early and to
late endosomal vesicles, respectively. Confocal microscopy analysis
revealed that disrupting Rab5 function by expression of a GFP-
tagged DN form of this protein, inhibited transferrin uptake
(Figure 4A). Then, transfected cells were challenged with the
37997 strain and processed for immunofluorescence. Intracellular
CHIKV, detected with mAbs reacting with capsid antigen, was
observed in cells overexpressing WT Rab5. In contrast, CHIKV
antigens were rarely detected in cells expressing the DN Rab5
GTPase (Figure 4B). Similar experiments were performed using
cells expressing a GFP-tagged WT or DN Rab7 transgene. After
CHIKV challenge, the percentage of virus-positive cells was only
slightly decreased by expression of DN Rab7 and was almost
unaffected by over expression of WT Rab7 (Figure 4C). For
quantitative studies, the fraction of infected cells was determined
by flow cytometry analysis of CHIKV antigen-positive cells. As
Figure2. CHIKV infection of HEK293T cells is inhibited by lysomotropic agents. (A)Cells were incubated in mediumsupplemented with drug
solvent (Med) or medium supplemented with appropriate concentrations of lysomotropic agents inhibiting endosomal acidification: chloroquine (Chl),
monensine (Mo), amonium chloride (NH4Cl), bafilomycine A1 (Baf). The cells were challenged with the 37997-GFP CHIKV strain used at a m.o.i. of 5. The
percentage of GFP-expressing cells was determined by flow cytometry analysis (black bars). For each experiment, the number of viable cells was
determined after exclusion coloration with Trypan Blue (white bars). Values are expressed as a percentage of untreated controls. Each value is the mean
of 3 separate experiments performed in triplicate 6 SD. (B) Appropriate concentrations of lysomotropic drugs were added to CHIKV infected cells
4 hours after viral challenge (m.o.i. of 5). After an additional 16 h in culture, percentage of infected cells was determined by flow cytometry.
doi:10.1371/journal.pone.0011479.g002
Figure 3. Methyl b-cyclodextrin treatment decreases infection
of mammalian cells by CHIKV. HEK293T cells were incubated in
medium alone or medium supplemented with increasing concentra-
tions of methyl b-cyclodextrin (mCD) and challenged with the 37997-
GFP CHIKV strain (m.o.i. of 5). The percentage of GFP expressing cells
was determined by flow cytometry analysis (black histograms). For each
experiment, the number of viable cells was determined after exclusion
coloration with Trypan Blue (white histograms). Values are expressed as
a percentage of untreated conditions. Each value is the mean of 3
separate experiments performed in triplicate 6 SD.
doi:10.1371/journal.pone.0011479.g003
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70%, the percentage of CHIKV-positive cells. In cells expressing
the DN Rab7 transgene, CHIKV infection was only moderately
reduced with a 30% decrease, when compared with cells
expressing WT Rab7 (Figure 4E). Accordingly, entry of CHIKV
in mammalian cells requires the integrity of early endosomes
whilst disruption of the late endosomal compartment has only a
very moderate impact on CHIKV infection.
Role of the cytoskeleton network in CHIKV endocytosis
Microtubules and actin microfilaments form most of the
cytoskeletal framework of the cell that determine, with the help of
motor proteins, endosomes and proteins and cargoes trafficking
within the cells [45,46,47]. Since the endosomal compartment is
required for CHIKV infection, the participation of the cytoskel-
eton can be inferred. In order to examine the role of intact
cytoskeleton microfilaments during infection, cells were treated
with specific depolymerizating agents prior to infection with
CHIKV. First, actin destabilization was achieved with cytocha-
lasin D, a fungal compound that disrupts microfilaments by
binding to the fast-growing end of the actin fiber [48]. The
capacity of drug treatment to destabilize actin fibers in
HEK293T cells was ascertained by immunofluorescence staining
of actin (Figure 5C). Then the cells were challenged with 37997-
GFP CHIKV. When compared with untreated cells, actin fiber
disruption reduced the percentage of infected cells by 48%
without decreasing cell viability (Figure 5A). The structural
integrity of the actin cytoskeleton is thus required for CHIKV
infection. We next examined the role of microtubules in CHIKV
infection using nocodazole, a reversible mitotic inhibitor that
binds to b-tubulin and interferes with microtubule polymerization
(Figure 5D). When cells treated with increasing concentrations of
this drug, ranging from 10 mMt o5 0mM, were challenged with
37997-GFP CHIKV, the percentage of GFP-expressing cells was
found reduced from 52% to 68% when compared with cells
maintained in medium supplemented with drug solvent
(Figure 5B). Cell viability was not significantly affected as assessed
by Trypan blue exclusion analysis. To discriminate between the
effects of inhibitors on entry or downstream processes, like gene
expression, we performed acid mediated by-pass assays. CHIKV
particles were bound to cells pretreated with cytoskeleton
depolymerizating agents. Cells were maintained at 4uC, and
then, medium was acidified to pH 5.0 to stimulate viral fusion.
After washes, infection was allowed to proceed for 16 hours
before analysis quantification of CHIKV-positive cells by flow
cytometry. As shown in Figure 5E, cytochalasine D or nocodazole
reduced infection levels in similar extent when cells were
challenged with CHIKV in neutral or acidic medium. Accord-
ingly, medium acidification did not by-passed blockade in
CHIKV replication caused by cytoskeleton disruption. Thus,
microtubules and actin-fibers integrity is required, at least, for a
post-fusion step of CHIKV life cycle.
Figure 4. Role of Rab5 and Rab7 GTPases in CHIKV infection of HEK293T cells. HEK293T cells grown on coverslips were transfected with
plasmids encoding either wild-type (WT) or dominant negative (DN) forms of GFP-tagged Rab5 (A), (B) and (D) or GFP-tagged Rab7 (C) and (E).
Twenty-four hours post-transfection, cells were challenged with CHIKV (37997 strain used at a m.o.i. of 5). After another 4 hours in culture, the cells
were permeabilized and viral antigens were labelled using anti-capsid C42 mAb and Alexa 594 secondary anti-Ig reagents. Antigen-expressing cells
were revealed by confocal imaging (B) and (C), or quantified by flow cytometry (D) and (E). In control experiments, cells expressing GFP-fused WT or
DN Rab5 were analyzed for Alexa Fluor 594-labelled transferrin uptake by confocal imaging (A). All experiments were repeated three times with
similar outcomes. Images are representative of individual cells visualized and percentages of CHIKV positive cells determined by flow cytometry
analysis are the mean of 4 separate experiments performed in triplicate 6 SD.
doi:10.1371/journal.pone.0011479.g004
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African and Indian Ocean strains of CHIKV
Strains circulating recently in the Indian Ocean have been
phylogenetically related to the African prototype of CHIKV. A
main divergence has been reported in the presence of an alanine-
to-valine mutation at position 226 in the E1 gene [26]. This
mutation has been related to the high pathogenicity observed in
some patients during the Indian Ocean outbreak. Moreover, E1-
A226V was found to improve CHIKV dissemination in Aedes
albopictus mosquitoes and increases dependence on cholesterol for
Figure 5. Effect of actin-disrupting drug and microtubule depolymerizating agent on CHIKV infection. HEK293T cells were treated with
increasing concentrations of (A) cytochalasin D (Cyt D) or (B) nocodazole (NoD) before exposure to the 37997-GFP strain of CHIKV (m.o.i. of 5) (black
bars). Sixteen hours post-infection, the percentage of infected cellswas determined by quantification of GFP-expressing cellsby flow cytometry analysis.
For each point, cell viability was determined by Trypan blue exclusion and expressed as a percentage of untreated controls (white bars). Values are the
mean of 3 separate experiments performed in duplicate + SD. Organization of cytoskeleton in cells cultured in medium alone (Med) or supplemented
with cytochalsin D (C) or nocodazole (D) was analyzed by immunofluorescence after labelling with anti-actin (C) or anti-tubulin mAbs (D). Nuclei are
stained with DAPI. (E) Flow cytometry analysis of CHIKV infected cells after treatment with cytochalasine D or nocodazole and viral challenge performed
in neutral (black bars) or acid (white bars) medium. Each value is the mean of 3 separate experiments performed in duplicate 6 SD.
doi:10.1371/journal.pone.0011479.g005
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recruited by the LR-OPY1-GFP isolate to infect mammalian cells
were thus investigated and compared with data obtained in the
present study using the 37997-GFP African strain (Figure 6).
Overall both strains were found to display a similar sensitivity
regarding expression of an Eps15 dominant negative transgene
(data not shown) and knock-down of clathrin heavy chain
(Figure 6A). The main difference observed when both CHIKV
isolates were compared was evidenced in infection assays
performed using cells treated with lysomotropic agents as a target
(Figure 6B). Interestingly, despite sensitive to pH acidification
inhibitors, the LR-OPY1-GFP isolate was 4 to 5 times less sensitive
to NH4Cl treatment than the 37997 African strain. Considering
chloroquine, monensin and bafilomycin A1, this tendency was
confirmed with a significantly reduced sensitivity of LR-OPY1
CHIKV to these chemical (p,0.031 in any case). Finally,
considering host cytoskeleton disrupting agents, sensitivity to
cytochalasin D and nocodazole was similar for the LR-OPY1 and
the 37997 strain of CHIKV (Figure 6C and 6D). These data
suggest that pathways used by the 3997-GFP African strain and
the LR-OPY1-GFP isolate may differ in some extent.
Discussion
The general entry model of alphaviruses into target cells relies
on endocytosis in the cell cytoplasm of receptor-bound viral
particles before the viruses are routed through endosomes along
the endocytic trafficking pathway. Fusion of the endosome and
virus membranes and entry of the viral capsid into the host cell
cytoplasm then requires the acidification of the environmental pH
[49,50,51]. Despite this general picture, a number of studies
evidenced marked differences with respect to entry mechanisms
used by closely related viruses, even when clustered within the
closely related subgroup of New World or Old World alphaviruses.
For example SFV, the prototype Old World alphavirus enters the
target cell by a the clathrin-dependent endocytosis and pH-
acidification [32] whereas entry of another Old World virus, SINV
may, according to some studies, not require the acidification of the
endocytic compartment [33]. Post-internalization, viruses may
follow two different endocytic trafficking routes: 1) the recycling
endosomes route or 2) the lysosome-targeted pathway where
acidification occurs and facilitates uncoating and fusion of
enveloped viruses. In the lysosomal pathway, the nature of
endosomes supporting the fusion events has been a matter of
debate. Several viruses from the alphavirus genus (e.g. SFV)
require Rab5-positive early endosomes but not a functional Rab7-
positive late endosomal compartment for productive entry and
infection [52,53]. Yet, other members of the alphavirus genus (e.g.
Venezuelan encephalitis virus) need to migrate through both early
and late endosomes before fusion can occur and viral genome is
released into the cytoplasm [34]. According to these divergences,
the routes utilized by CHIKV to infect its target cells cannot be
inferred based on previous experiments performed from related
viruses such as SFV and SINV. In this report we used diverse
chemical and molecular inhibitors together with dominant
negative proteins to explore CHIKV entry in mammalian cells.
We demonstrated that CHIKV entry into epithelial HEK293T
cells requires the presence, in the target cell, of functional Eps15.
Figure 6. Comparative analysis of entry pathways used by the 37997 African strain and the LR-OPY1 isolate to infect HEK293T cells.
Cells were challenged with normalized amounts (m.o.i. of 5) of the 37997-GFP (black bars) or the LR-OPY1-GFP (white bars) strains of CHIKV after (A)
transfection of cells with siRNA directed to clathrin heavy chain (CHC) or control siRNA (Ctrl), or after treatment with (B) lysomotropic agents
(chloroquine (Chl), monensin (Mo), amonium chloride (NH4Cl) or bafilomycin A1 (Baf)) or (C) cytochalasine D (CytD) or (D) nocodazole (NoD) in
conditions described inMaterial and Methods. For each experiment, a control performed by incubating the cells in the presence of medium
supplemented with an equivalent amount of drug solvent (Med) is included. Twenty-four hours post-infection, CHIKV replication was monitored by
flow cytometry analysis of GFP expression. Each value is the mean of 3 separate experiments performed in triplicate 6 SD.
doi:10.1371/journal.pone.0011479.g006
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vesicles, but also performs an important function in coupling
ubiquitinated cargo to clathrin-independent internalization [41].
Knock-down of clathrin-heavy chain helped deciphering with
those internalization pathways and showed that CHIKV infection
is independent of clathrin-coated vesicles formation. This result
was reproduced using the Hela cell line, a second model of
epithelial cells. These observations indicate that entry of CHIKV
into epithelial cells can be mediated, at least in some cell types, by
a clathrin-independent endocytosis.
The endosomal compartment required for CHIKV entry was
investigated by mean of overexpression of dominant negative
mutants of Rab-family GTPases that regulate transport, sorting
and maintenance of endosomal vesicles along the endocytic
pathway. Rab5 associates to early endosomal vesicles and is
required for the transport of early endosomes along the
microtubules [46,54]. Rab7 is a marker for late endosomes and
its activity regulates sorting of cargoes from early endosomes
toward the late endosome/lysosome pathway [55]. Overexpres-
sion of DN Rab5 and DN Rab7 mutants that result in constitutive
inactivation of endosome biogenesis has been widely used to study
trafficking pathways of viruses within the vesicular compartment
[55,56]. Here, we found that overexpression of DN Rab5 reduces
the susceptibility of mammalian cells to CHIKV infection,
supporting the hypothesis that this virus must access early
endosomes in order to productively infect mammalian cells. In
respect to this finding, CHIKV is similar to SFV that requires a
functional Rab5 for entering into its target [52]. In contrast, the
requirement for a functional Rab7-positive compartment is less
clear since only a moderate inhibition of CHIKV infection was
observed using DN Rab7 transfected cells. The role of Rab7 in
CHIKV entry needs further investigations. Indeed, despite
dispensable for SFV fusion which occurs in Rab5-positive
endosomes, enrichment with Rab7 and subsequent migration of
the virus contained in these Rab7-enriched domains along
microtubules was reported for SFV [52].
Once within the endosomal compartment, fusion of alpha-
viruses with the host cell membrane depends upon a low pH
microenvironment. For SFV, acidification allows insertion of
viral spike glycoproteins into the endosomal membrane and
subsequent delivery of the nucleocapsid into the cytoplasm [32].
All lysomotropic agents tested in the present study resulted in
the drastic inhibition of CHIKV infection, supporting the
hypothesis that entry in mammalian cells is strictly dependent
upon pH-acidification of intracellular vesicles. Analyzing the
consequences of cytoskeleton disruption using polymerization
inhibitors, we found that CHIKV infection requires both intact
actin microfilaments and microtubules. The contribution of
actin underlying the plasma membrane to endocytosis [57,58],
and also the function of microtubules in endosomal traffic from
peripheral early to late endosomes [57] render these microfil-
ament networks essential not only for initial internalization of
cargoes and viruses, but also for transportation through
endocytosis vesicles and finally in allowing viruses to reach the
nuclear compartment [59,60,61]. Having demonstrated here
that a productive CHIKV infection requires a functional early
endosomal compartment, the decreased viral infection observed
following actin and microtubule disruption may thus reflect the
requirement of intact cytoskeleton for endosomal trafficking.
Interestingly, the inability of acid mediated by-pass to restore
infectivity in cells treated with cytoskeleton depolymerizating
agents suggests that integrity of actin fibers and microtubules is
not only required for viral internalization, but also for a post-
fusion step of the viral life cycle.
Together with previously published informations [40], our data
indicate that CHIKV enters epithelial mammalian cells through a
clathrin-independent, Esp15-dependent, dynamin 2-dependent
route, requires a functional early endosomal compartment and is
dependent on endosomal acidification to reach productive
infection. Further studies will help to identify precisely the nature
of this entry pathway. It has to be kept in mind that virus
penetration in the target cell generally results from a balanced
usurpation of multiple endocytic pathways. In the present study, to
the exception of lysomotropic agents that drastically inhibited
CHIKV infection, viral entry was in any case only partly inhibited
by chemical drugs or dominant negative molecules interfering with
the cell endocytosis. This may support the hypothesis that several
pathways are hijacked by CHIKV to penetrate into its target cells.
In addition, entry pathways hijacked by viruses may vary
according to the target cell type [62]. In support of this idea, we
recently found that CHIKV productively infects the human
hepatoma HuH7 cell line [35] devoid of cav-1 required for
caveolar vesicles formation [63].
Overall entry pathways are mostly shared by the 37997 African
strain and the LR-OPY1 Reunion Island isolate of CHIKV
analyzed in the present study. Both viruses were equally impaired
by inhibition of Eps15 and cytoskeleton disruption. Although the
amino-acid residue present at position 226 within the E1 envelope
ectodomain was previously proposed to regulate the interaction of
the fusion loop with cholesterol in the target cell membrane
[29,64], we found that infection by the 37997 African prototype of
CHIKV (bearing a A226 a.a.) or by the LR-OPY1 isolate (bearing
a V226 a.a.) are equally inhibited by cholesterol-depleting agents.
These data contrast with other observations demonstrating that
the presence of the A226V mutation in the E1 gene is related to
different requirement for membrane cholesterol to infect mosquito
cell lines in vitro [30]. The main difference observed between both
strains is that LR-OPY1 strain is less dependent on pH
acidification of endosomes to infect mammalian cells. Require-
ment for low endocytic pH observed for CHIKV in the present
study is shared with SFV [49,50] but diverges from that of SINV,
another Old World alphavirus that can, in some cases establish
productive infection without the need for a pH-dependent
endocytic pathway [33,65]. Although the molecular mechanisms
underlying such differences are likely complex and elusive, it is
tempting to speculate that the genetic drift of viral isolates
circulating in the Indian Ocean area during the recent epidemic
[26] may be associated with the acquisition of alternative entry
mechanisms. Such an evolution has to be considered in developing
new antiviral strategies in response to a potential worldwide spread
of the Chikungunya virus.
Supporting Information
Figure S1 Role of clathrin-dependent endocytosis in CHIKV
infection of Hela cells. Subconfluent cultures of Hela cells were left
unstransfected (Mock) or transfected with siRNA targeting the
clathrin heavy chain (CHC) or with control siRNA (Ctrl.). (A)
Level of CHC expression in transfected cells was analyzed by
immunoblot. Actin expression was used to monitor proteins level
in each sample. (B) Transferrin uptake control was performed by
incubating cells with Alexa-594-labelled transferrin (5 mg/ml) for
30 min at 37uC. After washes, cells were fixed and processed for
fluorescence imaging. (C) 72 h post-transfection, the cells were
challenged with CHIKV (m.o.i. of 5). After another 16 h in
culture, cells were fixed and permeabilized, and viral antigens
were labelled with mAbs C42 and Alexa Fluor 594-conjugated
anti-mouse Ig secondary antibody. Percentage of infected cells was
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independent performed in duplicate 6 SD.
Found at: doi:10.1371/journal.pone.0011479.s001 (1.82 MB TIF)
Figure S2 Characterization of 37997-GFP and LR-OPY1-GFP
CHIKV strains replication in HEK293T cells. Replication kinetics
of increasing concentrations of (A) 37997-GFP CHIKV or (B) LR-
OPY1-GFP CHIKV in HEK293T cells was established flow
cytometry analysis of GFP expression at 7 h, 14 h and 24 h post-
infection (p.i.). Data are representative of 5 separate experiments.
It is worth noting that CHIKV is highly cytopathic and infected
cell cultures cannot be maintained for long periods of time.
Found at: doi:10.1371/journal.pone.0011479.s002 (1.32 MB TIF)
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